Restricted accessResearch articleFirst published online 2013-12
Induced Pluripotent Stem Cells from Friedreich Ataxia Patients Fail to Upregulate Frataxin During In Vitro Differentiation to Peripheral Sensory Neurons
The value of human disease models, which are based on induced pluripotent stem cells (iPSCs), depends on the capacity to generate specifically those cell types affected by pathology. We describe a new iPSC-based model of Friedreich ataxia (FRDA), an autosomal recessive neurodegenerative disorder with an intronic GAA repeat expansion in the frataxin gene. As the peripheral sensory neurons are particularly susceptible to neurodegeneration in FRDA, we applied a development-based differentiation protocol to generate specifically these cells. FRDA and control iPSC lines were efficiently differentiated toward neural crest progenitors and peripheral sensory neurons. The progress of the cell lines through discrete steps of in vitro differentiation was closely monitored by expression levels of key markers for peripheral neural development. Since it had been suggested that FRDA pathology might start early during ontogenesis, we investigated frataxin expression in our development-related model. A pronounced frataxin deficit was found in FRDA iPSCs and neural crest cells compared to controls. Whereas we identified an upregulation of frataxin expression during sensory specification for control cells, this increase was not observed for FRDA peripheral sensory neurons. This early failure, aggravating frataxin deficiency in a specifically vulnerable human cell population, indicates a developmental component in FRDA.
Get full access to this article
View all access options for this article.
References
1.
CampuzanoV, MonterminiL, LutzY, CovaL, HindelangC, JiralerspongS, TrottierY, KishSJ, FaucheuxB, et al. (1997). Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet, 6:1771–1780.
2.
CampuzanoV, MonterminiL, MoltoMD, PianeseL, CosseeM, CavalcantiF, MonrosE, RodiusF, DuclosF, et al. (1996). Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science, 271:1423–1427.
3.
KumariD and UsdinK. (2012). Is Friedreich ataxia an epigenetic disorder?. Clin Epigenetics, 4:2.
4.
SchmuckerS and PuccioH. (2010). Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches. Hum Mol Genet, 19:R103–R110.
5.
KoeppenAH, MorralJA, DavisAN, QianJ, PetrocineSV, KnutsonMD, GibsonWM, CusackMJ and LiD. (2009). The dorsal root ganglion in Friedreich's ataxia. Acta Neuropathol, 118:763–776.
6.
MorralJA, DavisAN, QianJ, GelmanBB and KoeppenAH. (2010). Pathology and pathogenesis of sensory neuropathy in Friedreich's ataxia. Acta Neuropathol, 120:97–108.
7.
KoeppenAH, DavisAN and MorralJA. (2011). The cerebellar component of Friedreich's ataxia. Acta Neuropathol, 122:323–330.
CosseeM, PuccioH, GansmullerA, KoutnikovaH, DierichA, LeMeurM, FischbeckK, DolleP and KoenigM. (2000). Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum Mol Genet, 9:1219–1226.
10.
LynchDR, DeutschEC, WilsonRB and TennekoonG. (2012). Unanswered questions in Friedreich ataxia. J Child Neurol, 27:1223–1229.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
LiuJ, VermaPJ, Evans-GaleaMV, DelatyckiMB, MichalskaA, LeungJ, CrombieD, SarseroJP, WilliamsonR, et al. (2011). Generation of induced pluripotent stem cell lines from Friedreich ataxia patients. Stem Cell Rev, 7:703–713.
15.
HickA, Wattenhofer-DonzeM, ChintawarS, TropelP, SimardJP, VaucampsN, GallD, LambotL, AndreC, et al. (2013). Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia. Dis Model Mech, 6:608–621.
16.
Le DouarinNM. (1990). Cell lineage segregation during neural crest ontogenya. Ann N Y Acad Sci, 599:131–140.
17.
KalcheimC and Burstyn-CohenT. (2005). Early stages of neural crest ontogeny: formation and regulation of cell delamination. Int J Dev Biol, 49:105–116.
18.
PavanWJ and RaibleDW. (2012). Specification of neural crest into sensory neuron and melanocyte lineages. Dev Biol, 366:55–63.
19.
PompO, BrokhmanI, Ben-DorI, ReubinoffB and GoldsteinRS. (2005). Generation of peripheral sensory and sympathetic neurons and neural crest cells from human embryonic stem cells. Stem Cells, 23:923–930.
20.
JiangX, GwyeY, McKeownSJ, Bronner-FraserM, LutzkoC and LawlorER. (2009). Isolation and characterization of neural crest stem cells derived from in vitro-differentiated human embryonic stem cells. Stem Cells Dev, 18:1059–1070.
21.
LeeG, ChambersSM, TomishimaMJ and StuderL. (2010). Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc, 5:688–701.
22.
Valensi-KurtzM, LeflerS, CohenMA, AharonowizM, Cohen-KupiecR, SheininA, AsheryU, ReubinoffB and WeilM. (2010). Enriched population of PNS neurons derived from human embryonic stem cells as a platform for studying peripheral neuropathies. PLoS One, 5:e9290
23.
ChambersSM, QiY, MicaY, LeeG, ZhangXJ, NiuL, BilslandJ, CaoL, StevensE, et al. (2012). Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat Biotech, 30:715–720.
24.
LeeKS, ZhouW, Scott-McKeanJJ, EmmerlingKL, CaiGY, KrahDL, CostaAC, FreedCR and LevinMJ. (2012). Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection. PLoS One, 7:e53010
25.
LiuQ, SpustaSC, MiR, LassiterRN, StarkMR, HokeA, RaoMS and ZengX. (2012). Human neural crest stem cells derived from human ESCs and induced pluripotent stem cells: induction, maintenance, and differentiation into functional schwann cells. Stem Cells Transl Med, 1:266–278.
26.
MenendezL, YatskievychTA, AntinPB and DaltonS. (2011). Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells. Proc Natl Acad Sci, 108:19240–19245.
27.
MenendezL, KulikMJ, PageAT, ParkSS, LauderdaleJD, CunninghamML and DaltonS. (2013). Directed differentiation of human pluripotent cells to neural crest stem cells. Nat Protoc, 8:203–212.
28.
LeeHY, KleberM, HariL, BraultV, SuterU, TaketoMM, KemlerR and SommerL. (2004). Instructive role of Wnt/beta-catenin in sensory fate specification in neural crest stem cells. Science, 303:1020–1023.
29.
SommerCA, StadtfeldM, MurphyGJ, HochedlingerK, KottonDN and MostoslavskyG. (2009). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells, 27:543–549.
30.
NatR, SaltiA, SuciuL, StromS and DechantG. (2012). Pharmacological modulation of the Hedgehog pathway differentially affects dorsal/ventral patterning in mouse and human embryonic stem cell models of telencephalic development. Stem Cells Dev, 21:1016–1046.
31.
LoringJF, WesselschmidtRL and SchwartzPH, eds. (2007). Part II: characterization of Stem Cells. In: Human Stem Cell Manual. Elsevier Academic Press, San Diego, CA, pp. 59–70.
32.
PfafflMW. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 29:e45.
33.
DeutschEC, SantaniAB, PerlmanSL, FarmerJM, StolleCA, MarusichMF and LynchDR. (2010). A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Mol Genet Metab, 101:238–245.
34.
Garcia-CastroMI, MarcelleC and Bronner-FraserM. (2002). Ectodermal Wnt function as a neural crest inducer. Science, 297:848–851.
35.
HariL, BraultV, KleberM, LeeHY, IlleF, LeimerothR, ParatoreC, SuterU, KemlerR and SommerL. (2002). Lineage-specific requirements of beta-catenin in neural crest development. J Cell Biol, 159:867–880.
36.
BettersE, LiuY, KjaeldgaardA, SundstromE and Garcia-CastroMI. (2010). Analysis of early human neural crest development. Dev Biol, 344:578–592.
37.
LeeG, KimH, ElkabetzY, AlSG, PanagiotakosG, BarberiT, TabarV and StuderL. (2007). Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat Biotechnol, 25:1468–1475.
38.
MarmigereF and ErnforsP. (2007). Specification and connectivity of neuronal subtypes in the sensory lineage. Nat Rev Neurosci, 8:114–127.
39.
FedtsovaNG and TurnerEE. (1995). Brn-3.0 expression identifies early post-mitotic CNS neurons and sensory neural precursors. Mech Dev, 53:291–304.
40.
AndersonDJ. (1999). Lineages and transcription factors in the specification of vertebrate primary sensory neurons. Curr Opin Neurobiol, 9:517–524.
41.
MizusekiK, SakamotoT, WatanabeK, MugurumaK, IkeyaM, NishiyamaA, ArakawaA, SuemoriH, NakatsujiN, et al. (2003). Generation of neural crest-derived peripheral neurons and floor plate cells from mouse and primate embryonic stem cells. Proc Natl Acad Sci, 100:5828–5833.
42.
SunY, DykesIM, LiangX, EngSR, EvansSM and TurnerEE. (2008). A central role for Islet1 in sensory neuron development linking sensory and spinal gene regulatory programs. Nat Neurosci, 11:1283–1293.
43.
ErnsbergerU. (2009). Role of neurotrophin signalling in the differentiation of neurons from dorsal root ganglia and sympathetic ganglia. Cell Tissue Res, 336:349–384.
44.
KramerI, SigristM, de NooijJC, TaniuchiI, JessellTM and ArberS. (2006). A role for Runx transcription factor signaling in dorsal root ganglion sensory neuron diversification. Neuron, 49:379–393.
45.
JiralerspongS, LiuY, MonterminiL, StifaniS and PandolfoM. (1997). Frataxin shows developmentally regulated tissue-specific expression in the mouse embryo. Neurobiol Dis, 4:103–113.
46.
LuC, SchoenfeldR, ShanY, TsaiHJ, HammockB and CortopassiG. (2009). Frataxin deficiency induces Schwann cell inflammation and death. Biochim Biophys Acta, 1792:1052–1061.
47.
PandolfoM. (2012). Friedreich ataxia: new pathways. J Child Neurol, 27:1204–1211.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
